SPECIAL ISSUE GUEST-EDITORS: 

Sophie Erhardt, Karolinska Institutet, Sweden and Michael E. Benros, University of Copenhagen, Denmark

Immunopsychiatry has significantly advanced our understanding of the link between the immune system and mental health, revealing how immune dysregulation can impact psychiatric disorders. This field is instrumental in developing innovative treatments, marking a transformative shift in mental health research and patient care.

Acta Neuropsychiatrica announces a call for submissions to a special issue titled "Progress in Immunopsychiatry," dedicated to showcasing the latest advancements in the field. This issue aims to cover a wide range of topics, from preclinical science to cutting-edge overviews of new drugs in clinical trials to comprehensive epidemiological studies, underscoring the relevance in the pathophysiology of neuropsychiatric disorders.

We invite researchers to contribute original articles and review papers that provide fundamental insights into both clinical and preclinical studies, with a particular emphasis on novel findings in disease mechanisms.

Learn more about how to submit here.

Final submissions will be due December 1st 2024. 

All submissions will be peer-reviewed.